Clinical Trial Update: A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LY900014 to insulin lispro in adults with Type 2 diabetes mellitus has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY900014
• insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-03-27